On Feb. 8 the U.S. Food and Drug Administration approved the cholesterol-lowering medication Crestor (rosuvastatin) for some patients who are at increased risk of heart disease but have not been diagnosed with it. The new…
February 19, 2010 -- The U.S. Food and Drug Administration today announced that drugs in the class of long-acting beta agonists (LABAs) should never be used alone in the treatment of asthma in children or…
Early Communication about an Ongoing Safety Review of Meridia (sibutramine hydrochloride)This information reflects FDA's current analysis of available data concerning this drug. FDA is considering, but has not reached a conclusion about whether this information…
PRESS RELEASE: CMDh confirms recommendations on restricting use of domperidone-containing medicinesThe Co-ordination Group for Mutual Recognition and Decentralised Procedures – Human (CMDh) has endorsed recommendations to restrict the use of domperidone-containing medicines. The CMDh, a…

Introduction

The  Hospital Pharmacists Association of Kenya (HOPAK) provides a dynamic platform for the exchange of knowledge among sector players to enhance their contributions to health. We provide timely scientific programs, ongoing education, opportunities for networking, and professional development.

Our website is a resource portal for all practicing hospital and institutional pharmacists in Kenya.

Contact us

Hospital Pharmacists Association of Kenya (HOPAK)
P. O. Box 19859 00202
Nairobi - Kenya
info@hopak.or.ke